falsefalse

Screening and Treatment for Lung Cancer: What's Next? - Episode 1

Introduction to Lung Cancer Screening and Treatment

The second part of the webinar Lung Cancer Screening and Treatment: What's Next? focuses on the review of lung cancer screening and treatment status amid the COVID-19 pandemic. Participating faculty include Albert Rizzo, MD, FCCP, FACP, FAASM; James L. Mulshine, MD; Andrea Borondy Kitts, MS, MPH; and Sandip Patel, MD.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    Now Viewing
    EP. 1: Introduction to Lung Cancer Screening and Treatment
    EP. 2: Effective Lung Cancer Screening Leads to Opportunities
    EP. 3: What Are the Current Treatment Options in Lung Cancer?
    EP. 4: Novel Agents Emerging in the Lung Cancer Pipeline
    EP. 5: Utilizing Patient-Friendly Pathways in Lung Cancer Diagnostics and Treatment
    EP. 6: Future Strategies With Lung Cancer Screening

    The second part of the webinar Lung Cancer Screening and Treatment: What's Next? focuses on the review of lung cancer screening and treatment status amid the COVID-19 pandemic. Participating faculty include Albert Rizzo, MD, FCCP, FACP, FAASM; James L. Mulshine, MD; Andrea Borondy Kitts, MS, MPH; and Sandip Patel, MD.

    Related Content:

    Screening and Treatment for Lung Cancer: What's Next?Lung Cancer
    Final Thoughts on the Treatment of EGFR-Mutant NSCLC: Balancing Safety and Efficacy, and the Importance of Incorporating Supportive Care Strategies
    The Future of Biomarkers in EGFR-Mutant NSCLC: Sequencing Strategies and Optimizing Patient Time on Treatment
    Treatment Options in the Second-Line for CNS Protection In EGFR-Mutant NSCLC
    x